semaglutide 5 mg 5mg — Selective GLP-1 Receptor Agonist — Research Peptide – Prime Labs Semaglutide (GLP-1)

2.4 mg dose = 0.96 mL (96 units)

Niacinamide rounds out the formula by correcting uneven skin tone and promoting a clearer, more luminous complexion

No compounded peptide formulations are not FDA-approved drug products and are categorically excluded from insurance coverage, including FSA and HSA reimbursement in most cases

Laboratory studies have explored its role in: Cell culture and proliferation assays Molecular binding and receptor interaction studies Tissue regeneration and wound healing models Biochemical pathway analysis Pharmacokinetic and stability profiling Note: KLOW sold by CoreVionRX is intended strictly for research purposes